Behavioral Intervention

clinician-mediated JASPER for Autism Spectrum Disorder

UCLA, Los Angeles, CA

Targeting 2 different conditionsclinician-mediated JASPER +1 moreN/ARecruitingResearch Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Must not have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Upentry (1st month of the study), t2 (10 weeks after entry), t3 (20 weeks after entry)

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will study whether JASPER, a play-based intervention, is effective in treating children with autism spectrum disorder. The trial will last 3 years, recruiting 90 participants (10 per site per year) from Boston University, UCLA, and Weill Cornell. The participants will be randomized to receive JASPER from either a clinician or their caregiver, and after 10 weeks, will be evaluated to see if they respond to the treatment. Nonresponders will then receive a mix of clinician and caregiver-facilitated JASPER, while responders will continue to receive the same treatment for an additional 10 weeks. The outcome of

Eligible Conditions

Autism Spectrum Disorder
Autism

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ entry (1st month of the study), t2 (10 weeks after entry), t3 (20 weeks after entry)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~entry (1st month of the study), t2 (10 weeks after entry), t3 (20 weeks after entry)

This trial's timeline: 3 weeks for screening, Varies for treatment, and entry (1st month of the study), t2 (10 weeks after entry), t3 (20 weeks after entry) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in frequency of language utterances and number of conversation turns using the Elicitation of Language Samples for Analysis- Toddlers (ELSA-T)

Change in social communication using the Brief Observation of Social Communication Change (BOSCC)

Other outcome measures

ADOS Toddler Module or Module 1 or Module 2 (depends on child's language level)

Change in Joint Engagement on the Caregiver-Child Play Interaction (CCX) over the course of the study.

Demographic and Medical Questionnaire

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: parent-mediated JASPERExperimental Treatment1 Intervention

This group will consist of the therapist assisting the parent implement JASPER on the child twice a week.

Group II: clinician-mediated JASPERExperimental Treatment1 Intervention

This group will consist of the child and therapist having one-on-one, JASPER sessions, twice a week.

Do I qualify?Apply below to find out

Find a site

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,467 Previous Clinical Trials

10,148,752 Total Patients Enrolled

24 Trials studying Autism Spectrum Disorder

4,259 Patients Enrolled for Autism Spectrum Disorder

Simons FoundationOTHER

7 Previous Clinical Trials

6,166 Total Patients Enrolled

5 Trials studying Autism Spectrum Disorder

1,141 Patients Enrolled for Autism Spectrum Disorder

Media Library

JASPER (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04146428 — N/A

Autism Spectrum Disorder Research Study Groups: clinician-mediated JASPER, parent-mediated JASPER

Autism Spectrum Disorder Clinical Trial 2023: JASPER Highlights & Side Effects. Trial Name: NCT04146428 — N/A

JASPER (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04146428 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been selected to take part in this research initiative?

"To fulfill the trial requirements, 90 individuals who meet all of the eligibility criteria must participate. The Semel Institute in Boston and BU White Plains are two medical centers which currently offer this clinical trial."

Answered by AI

Does this research still have vacancies open to the public?

"According to the clinicaltrials.gov documents, enrollment is still open for this trial that was first advertised on 27th April 2021 and last modified on 2nd September 2022."

Answered by AI